Published in Proc Natl Acad Sci U S A on August 01, 1986
Monoclonal antibodies with exclusive reactivity against parathyroid cells and tubule cells of the kidney. Proc Natl Acad Sci U S A (1987) 1.06
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem (1981) 71.15
Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun (1978) 32.33
Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature (1977) 16.54
Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril. Biochemistry (1978) 9.04
Use of monoclonal anti-mouse immunoglobulin to detect mouse antibodies. Hybridoma (1981) 3.58
Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies. J Exp Med (1985) 1.77
Isolation of variants of mouse myeloma X63 that express changed immunoglobulin class. Proc Natl Acad Sci U S A (1980) 1.76
The in vivo localization of anti-Wagner-osteogenic-sarcoma antibodies. Cancer (1953) 1.41
Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants. J Immunol (1986) 1.40
Preparation of viable isolated bovine parathyroid cells. Endocrinology (1976) 1.22
Transplantation of the parathyroid glands in dogs. Biochemical, histological, and radioimmunoassay proof of function. Transplantation (1973) 1.16
Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies. Science (1982) 1.14
Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants. Proc Natl Acad Sci U S A (1985) 1.02
Isolation and partial characterization of secretory protein I from bovine parathyroid glands. Biochemistry (1981) 0.95
Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting. Cancer Metastasis Rev (1983) 0.92
Effects of chemotherapeutic agents on two lines of human breast carcinomas in tissue culture. Surg Gynecol Obstet (1969) 0.90
Radiolocalization of xenografted human malignant melanoma by a monoclonal antibody (9.2.27) to a melanoma-associated antigen in nude mice. Cancer Res (1985) 0.87
Selection of hybridomas and hybridoma variants using the fluorescence activated cell sorter. J Immunol Methods (1982) 0.86
Cellular distribution of monoclonal antibody in human tumours after i.v. administration. Br J Cancer (1981) 0.86
In vivo tumor localization using tumor-specific monkey xenoantibody, alloantibody, and murine monoclonal xenoantibody. Ann Surg (1981) 0.84
Biosynthesis, processing, and secretion of parathormone and secretory protein-I. Recent Prog Horm Res (1983) 0.84
Studies in vascular permeability. II. Comparative extravasation of different immunoglobulin classes in normal guinea pig skin. Eur J Immunol (1973) 0.84
Monoclonal antibodies to breast cancer-associated antigens as potential reagents in the management of breast cancer. Cancer (1984) 0.83
Localization of an anti-CEA monoclonal antibody in colo-rectal carcinoma xenografts. Cancer Immunol Immunother (1985) 0.82
Distribution of IgM monoclonal antibody in mice with human tumour xenografts: lack of tumour localization. Eur J Cancer Clin Oncol (1985) 0.82
Imaging of human tumor xenografts in nude mice with radiolabeled monoclonal antibodies. Limitations of specificity due to nonspecific uptake of antibody. Cancer (1984) 0.79
Time course localization of immunoglobulin M monoclonal antibody and its fragments in leukemic tumor-bearing mice. Cancer Immunol Immunother (1985) 0.78
Human parathyroid gland: a freeze fracture and thin section study. Curr Top Pathol (1977) 0.78
Radioimmunoimaging of human small cell lung carcinoma with I-131 tumor specific monoclonal antibody. Hybridoma (1985) 0.77
Tumor localization of Lewis lung carcinoma with radiolabeled monoclonal antibodies. Cancer Immunol Immunother (1984) 0.77
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Subclass restriction of murine anti-carbohydrate antibodies. J Immunol (1978) 4.99
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet (1993) 4.38
Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res (1995) 3.38
Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nucl Med Biol (1997) 3.25
Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc Natl Acad Sci U S A (1984) 3.14
Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency. J Exp Med (1980) 3.13
A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol (1984) 3.11
Receptors on immunocompetent cells. II. Specificity and nature of receptors on dinitrophenylated guinea pig albumin- 125 I-binding lymphocytes of normal guinea pigs. J Exp Med (1971) 2.92
Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet (1997) 2.88
Effect of teichoic acid on resistance to the membrane-lytic agent of Streptococcus zymogenes. J Bacteriol (1966) 2.87
In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjug Chem (2000) 2.30
Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci U S A (1994) 2.25
Depletion of antibody-forming cells and their precursors from complex lymphoid cell populations. J Immunol (1972) 2.24
Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. J Clin Oncol (2001) 2.20
The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways. J Biol Chem (2000) 2.17
A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2001) 2.15
Syrinx 2A: an improved lambda phage vector designed for screening DNA libraries by recombination in vivo. Proc Natl Acad Sci U S A (1987) 2.11
Receptors on immunocompetent cells. 3. Specificity and nature of receptors on dinitrophenylated guinea pig albumin- 125 I-binding cells of immunized guinea pigs. J Exp Med (1971) 2.11
Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ (1996) 2.09
Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up. Ann Surg (1996) 2.06
Receptors on immunocompetent cells. V. Cellular correlates of the "maturation" of the immune response. J Exp Med (1972) 2.03
Clonal nature of the immune response to phosphorylcholine. IV. Idiotypic uniformity of binding site-associated antigenic determinants among mouse antiphosphorylcholine antibodies. J Exp Med (1974) 2.02
Clonal nature of the immune response to phosphorylcholine. II. Idiotypic specificity and binding characteristics of anti-phosphorylcholine antibodies. J Immunol (1974) 1.95
Amino acid sequence of homogeneous antibodies to dextran and DNA rearrangements in heavy chain V-region gene segments. Nature (1980) 1.94
Expression of focal adhesion kinase gene and invasive cancer. Lancet (1993) 1.93
Radiometal-labeled agents (non-technetium) for diagnostic imaging. Chem Rev (1999) 1.93
Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. Clin Exp Immunol (1983) 1.88
Indium-111-labeled leukocytes for the localization of abscesses: preparation, analysis, tissue distribution, and comparison with gallium-67 citrate in dogs. J Lab Clin Med (1977) 1.87
Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol (1996) 1.87
Clonal nature of the immune response to phosphorylcholine. I. Specificity, class, and idiotype of phosphorylcholine-binding receptors on lymphoid cells. J Exp Med (1974) 1.85
Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med (1982) 1.85
Transplantation of the parathyroid glands in man: clinical indications and results. Surgery (1975) 1.84
Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS. Science (1979) 1.82
Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet (1994) 1.79
Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer (1999) 1.74
Functional consequences of posttranslational isomerization of Ser46 in a calcium channel toxin. Science (1994) 1.73
Action of streptolysin S, the group D hemolysin, and phospholipase C on whole cells and spheroplasts. J Bacteriol (1966) 1.72
Receptors on immunocompetent cells. I. Receptor specificity of cells participating in a cellular immune response. Cell Immunol (1970) 1.70
High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci U S A (2000) 1.69
Tumors of the small intestine. Semin Oncol (1988) 1.66
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J Nucl Med (1999) 1.62
Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. Thromb Res (1976) 1.61
Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins. J Nucl Med (1993) 1.56
Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals. J Nucl Med (1983) 1.55
Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect. J Exp Med (1979) 1.54
Breast cancer: PET imaging of estrogen receptors. Radiology (1988) 1.53
The in vivo behavior of copper-64-labeled azamacrocyclic complexes. Nucl Med Biol (1998) 1.52
L2C Guinea pig lymphatic leukemia: a "B" cell leukemia. Blood (1972) 1.52
A comparison of pentagastrin injection and calcium infusion as provocative agents for the detection of medullary carcinoma of the thyroid. J Clin Endocrinol Metab (1974) 1.52
Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg (1980) 1.51
Cross-reactions of the group-specific polysaccharides of streptococcal groups B and G in anti-pneumococcal sera with especial reference to type 23 and its determinants. J Immunol (1967) 1.51
Electrophoretic analysis of polypeptide chains isolated from antibodies in the serum of immunized rabbits. J Immunol (1967) 1.51
Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. J Nucl Med (2001) 1.51
Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy. Eur J Nucl Med (1999) 1.49
MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans. Neurology (1987) 1.49
Blood-brain barrier permeability of 11C-labeled alcohols and 15O-labeled water. Am J Physiol (1976) 1.48
Parathyroid adenomas in the aortopulmonary window. Radiology (1996) 1.46
Role of T lymphocytes in the humoral immune response. I. Proliferation of B lymphocytes in thymus-deprived mice. J Immunol (1974) 1.46
Structural correlates of cross-reactive and individual idiotypic determinants on murine antibodies to alpha-(1 leads to 3) dextran. J Exp Med (1980) 1.46
In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62. J Nucl Med (1991) 1.46
Membrane-associated immunoglobulin of rabbit peripheral blood lymphocytes: allelic exclusion at the b locus. Proc Natl Acad Sci U S A (1971) 1.45
Parathyroid transplantation. World J Surg (1977) 1.45
The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. Cell Growth Differ (1998) 1.44
Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes. Cancer Res (1992) 1.43
The early diagnosis of medullary carcinoma of the thyroid gland in patients with multiple endocrine neoplasia type II. Ann Surg (1975) 1.43
In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: a potential approach for identification of jeopardized myocardium. J Am Coll Cardiol (1990) 1.42
Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg (1994) 1.41
Receptor tyrosine kinases expressed in metastatic colon cancer. Int J Cancer (1995) 1.41
Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol (2001) 1.39
Receptors on immunocompetent cells. IV. Direct measurement of avidity of cell receptors and cooperative binding of multivalent ligands. J Exp Med (1972) 1.38
Preparation and evaluation of 111In-labeled leukocytes as an abscess imaging agent in dogs. Radiology (1976) 1.36
Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. Clin Cancer Res (1996) 1.35
Lethality of multiple endocrine neoplasia type I. World J Surg (1998) 1.35
Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med (1995) 1.34
Subclass restriction of murine antibodies. III. Antigens that stimulate IgG3 in mice stimulate IgG2c in rats. J Exp Med (1980) 1.34
Special report. Steriod receptors in breast cancer. N Engl J Med (1979) 1.33
Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma. Ann Surg (1978) 1.33
Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Ann Surg (1993) 1.32
Hapten-specific tolerance. Preferential depression of the high affinity antibody response. J Exp Med (1972) 1.31
Copper-64-labeled antibodies for PET imaging. J Nucl Med (1992) 1.29
Homodimeric and heterodimeric bis(amino thiol) oxometal complexes with rhenium(V) and technetium(V). Control of heterodimeric complex formation and an approach to metal complexes that mimic steroid hormones. J Med Chem (1994) 1.29
B cell subsets and differential responses to mitogens. Immunol Rev (1982) 1.26
Isoelectric focusing of immunoglobulins: improved methodology. J Immunol Methods (1980) 1.26
Multiple VH gene segments encode murine antistreptococcal antibodies. J Exp Med (1984) 1.26
Synthetic idiotypes: the third hypervariable region of murine anti-dextran antibodies. Cell (1983) 1.26
A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer. N Engl J Med (1981) 1.26
Cell surface antigens expressed by subsets of pre-B cells and B cells. J Immunol (1984) 1.26
The transplanted parathyroid gland: evaluation of cryopreservation and other environmental factors which affect its function. Surgery (1974) 1.25
Evaluation of a breast cyst fluid protein detectable in the plasma of breast carcinoma patients. Ann Surg (1977) 1.25
Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging. Ann Surg (1978) 1.25
Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland. Ann Surg (1978) 1.25
Parathyroid autotransplantation in primary parathyroid hyperplasia. N Engl J Med (1976) 1.25
Clonal dominance. I. Restricted nature of the IgM antibody response to group A streptococcal carbohydrate in mice. J Exp Med (1975) 1.24
Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br J Surg (1986) 1.24